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ABSTRACT 
Availability of practical simple early indicators of worsening risk of dengue infection in pediatric patients would serve alert for monitoring and 
timely fluid replacement to avert the shock syndrome. Liver involvement in dengue shock syndrome(DSS) is known, hence role of serum liver 
enzyme monitoring as practical predictor of risk of DSS was investigated 
50 DSS and 63 non-DSS  pediatric dengue patients were compared on clinic laboratory parameters at admission to draw relevant distinctions . 
DSS patients were distinguished by frequent complaint of abdominal pain,hepatomegaly,elevated hematocrit and serum aspartate transaminase 
levels relative to non-DSS cases. 
Regular serum liver enzyme monitoring is suggested as worthwhile for predicting patients at greater risk of developing DSS.Close monitoring of 
shock and timely fluid replacement in such patients should improve outcome. 
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INTRODUCTION 
Dengue is mosquito borne viral disease responsible for significant 
morbidity and mortality in the tropical countries [1]. Disease 
severity in dengue ranges from undifferentiated acute febrile illness 
to dengue fever (DF), to dengue hemorrhagic fever (DHF), to dengue 
shock syndrome (DSS), associated with vascular plasma leakage [2]. 
Dengue affects liver too [3]. Hepatic dysfunction is common is 
common in dengue infection and attributed to direct viral damage to 
liver cells or as a consequence of deregulated host immune response 
etc [4]. Hepatic dysfunction is reflected by mild to severe elevation 
of transaminase levels. Some studies found DF, DHF and DSS cases 
showing different degrees of elevations in aspartate 
aminotransferase (AST) and alanine amino transferase (ALT) levels 
[5,6], while other studies have not reported this[7,8]. Present study 
gathers the evidence in pediatric patients from northern India 
region, managed at Gorakhpur medical college hospital. 
PATIENTS AND METHOD  
The study is based on data of hospitalized dengue patients in 
pediatrics ward of BRD medical college Gorakhpur, between January 
2012 to June 2013. Protocol of the observational study was 
approved by administration. Patients guardians were explained that 
information relating the treatment of patient is worthwhile inclusion 
in research and identities would not be revealed without their 
concurrence, and their verbal consents were obtained. All patients in 
age range from 2 year to 15 years, clinically diagnosed dengue as per 
WHO criteria [1], were included. Children with history of hepatitis or 
otherwise diagnosed with immune disorders, hemato-oncological 
disease were excluded. Patients receiving standard care were 
monitored for presumable DSS. Those developing DSS were 
categorized as cases and others not developing DSS served as 
control group for comparison. 
Complete blood examination were carried out upon diagnosis and 
serum aliquots were collected and stored at 40C till estimation of 
transaminase levels. Clinical history of fever duration, symptoms of 
abdominal pain, nausea and vomiting; examination for cutaneous or  
 
 
mucosal bleeds and hepatomegaly were particularly made. Baseline 
hematocrit, leukocyte count, platelet count and hemoglobin 
concentration were determined as well. Chi square statistic was 
employed for bivariate analyses of comparison. Distribution 
frequency of patients in case and control groups around common 
median and other category variables was studied. 
OBSERVATIONS AND RESULT  
Following the eligibility criteria during the study period, 50 patients 
got assigned as DSS cases while 63 non DSS cases roughly matching 
fever duration were enrolled from contemporary admissions as 
control. Baseline clinic-laboratory characteristics of cases in the two 
groups are presented in Table.1. 
Median age of the studied patient sample was 68 months and 
composition of compared groups did not significantly differ in age or 
gender. Median fever duration  at admission was 4 days and no 
significant difference in the groups was observed. Frequencies of 
petechial or mucosal bleeds also did not significantly differ in two 
groups. Abdominal pain was complained by significantly high 
proportion(78%) of DSS patients in contrast to only 25% of non-DSS 
controls. Nausea and vomiting was also insignificantly more 
frequent in DSS group. Significantly high76% of DSS cases had 
hepatomegaly as opposed to in only 30% among controls. Among 
the hematological tests, Leukocyte counts did not decline in majority 
of DSS patients while majority of control had lower counts, however 
difference was not significant. No significant difference was seen 
among two groups in respect of platelet counts. Hematocrit was 
increased in significantly higher proportion (72%) of DSS cases in 
contrast to just in 3% of controls.DSS patients also had significantly 
very high prevalence(94%) of low hemoglobin contrary to only 
50.8% in control. Serum transaminase AST profile was elevated in 
significantly high proportion(80%) of DSS cases as opposed to only 
in 20% of controls.ALT levels were higher only in 42% of DSS cases 
but this proportion was significantly high than bare 3% observed in 
non-DSS control group. Finally, there was no significant difference in 
rate of positive serological tests for dengue in the two groups. 
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Table 1: Clinical and laboratory characteristics of DSS cases and non-DSS control group among pediatric dengue infection patients 
Charecteristic DSS group(n=50) Control group(n=63) p 
Age(median 68 months) <68 m 29 26  
>68m 21 37  
Gender Male 27 34  
Female 23 29  
Fever duration at adm.(median 4 days) < 4d 30 28  
>4d 20 35  
Clinical features 
Bleeds Present 28 26  
Absent 22 37  
Abdominal pain Present 39(78%) 16(25.4%)    * 
Absent 11 47  
Nausea/vomiting Present 28(56%) 27(42.8)  
Absent 22 36  
Liver enlargement Present 38(76%) 19(30%) * 
Absent 12 44  
Leukocyte ct.Median 4000/mcr.l <4000 16 (32%) 33 (52%)  
>4000 34 30  
Platelet ct.Median 52000/mcr l    <52000 32 45  
>52000 18 18  
Hematocrit level >46% 36(72%) 2(3.2%) * 
 <46% 14 61  
Haemoglobin % <14% 47(94%) 32(50.8%) * 
 >14% 3 31  
Transaminases IU/L 
AST >130 40(80%) 13(20.6%) * 
< 130 10 50  
ALT > 40 21(42%) 2 (3.2) * 
<40 29 61  
Serology Dengue IgG &IgM positive 40 45  
Negative 10 18  
*Indicates statistically significant difference                                                                                                                              
 
DISCUSSION           
Only a modest cut off for rise in AST (about 3 times upper normal), 
and very minor rise above normal for ALT were adopted for 
balanced comparison. Association of raised AST level but not ALT 
level in DSS has been reported[4,6].Liver cell damage in dengue may 
be due to direct cytopathic effect of virus; immunologic liver cell  
destruction or shock that leads to ischemia of hepatocytes [7]. 
Necrosis of liver cells in dengue is found to occur in mid and 
centrolobular zones, which are very sensitive to anoxic and cytokine 
mediated injury [8]. Serum transaminase levels are reported to 
begin rising on third day of dengue fever, reaching peak by 9th day 
and gradually subsiding thereafter over 2 to 3 weeks[9,10].Upon an 
overview, presenting features as abdominal pain, hepatomegaly, 
elevated hematocrit and AST enzyme levels should warn of the risk 
of patient worsening to DSS. Although plasma leakage and bleeding 
are hardly preventable, the understanding of variables related to 
DSS should alert for monitoring early onset of DSS. Close monitoring 
of imminent shock and timely fluid replacement would halt 
deterioration of the patient[11].Hepatic injury in dengue patients 
associates complications and hence it is prudent to regularly 
monitor serum transaminase levels in dengue patients as quality 
care and better outcomes[12]. 
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